Advertisement

Mycopathologia

, Volume 180, Issue 1–2, pp 69–73 | Cite as

Neonatal Candidemia Caused by Candida haemulonii: Case Report and Review of Literature

  • Carolina M. Silva
  • Ana M. R. Carvalho-Parahym
  • Danielle P. C. Macêdo
  • Reginaldo G. Lima-Neto
  • Elaine C. Francisco
  • Analy S. A. Melo
  • Maria da Conceição M. Silva
  • Moacir B. Jucá
  • Luciana R. B. Mello
  • Rosemary M. J. Amorim
  • Rejane P. Neves
Article

Abstract

Candidemia is a frequent condition in Neonatal Intensive Care Units (NICU) and usually complicates the newborns clinical course. Several factors are responsible for candidiasis, such as prematurity and use of broad-spectrum antibiotics, and in these cases, there are the involvement of various Candida species, as C. albicans, and C. parapsilosis. However, other species as C. haemulonii has been rarely described in candidemia cases, being considered an emergent pathogen. Thus, we report a case of neonatal candidemia by C. haemulonii and a review of literature of fungemia by this yeast. The patient was a neonate with gestational age of 26 weeks and birth weight of 660 g hospitalized in a NICU from a Brazilian hospital. The identification of the etiological agent was performed by phenotypic methods, scanning electron microscopy, sequencing of the ITS region of rDNA, and mass spectrometry. Antifungal susceptibility testing was carried out according to the Clinical Laboratories and Standards Institute guidelines. The newborn was diagnosed with candidemia by C. haemulonii resistant to amphotericin B with minimal inhibitory concentration (MIC) of 8 µg/mL, sensitive to fluconazole (MIC: 8 µg/mL) and voriconazole (MIC: 0.12 µg/mL). The treatment with fluconazole (12 mg/kg/day) was established with good outcome. Candidemia by C. haemulonii is still being limited to a few sporadic cases in adults with endemic and restricted occurrences in neonates. Usually, the therapy with amphotericin B is ineffective against this species. Our results showed the importance of the mycological diagnosis associated to antifungigrama for the successful clinical management followed by important epidemiological data.

Keywords

Candidemia Neonates Neonatal Intensive Care Unit Emerging pathogen Antifungal sensibility Candida haemulonii 

Notes

Acknowledgments

We thank the Coordination of Improvement of Higher Education Personnel (CAPES) for funding. We acknowledge the Special Mycology Laboratory—EPM/UNIFESP, Brazil, for DNA sequencing and CETENE for scanning electronic microscopy analysis.

References

  1. 1.
    Hammoud MS, Altair A, Fouad M, Raina A, Khan Z. Persistent candidemia in neonatal care units: risk factors and clinical significance. Int J Infect Dis. 2013;17:624–8.CrossRefGoogle Scholar
  2. 2.
    Panackal AA. Optimizing containment and control of Candida parapsilosis fungemia among neonates in the outbreak setting using a mathematical modeling approach. J Mycol. 2013;2013:11.Google Scholar
  3. 3.
    Blyth CC, Chen SC, Slavin MA, et al. Australian Candidemia Study. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics. 2009;123:1360–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Arendrup MC, Fisher BT, Zaoutis TE. Invasive fungal infections in pediatrics and neonatal population: diagnostics and management issues. Eur Soc Clin Microbiol Infect Dis. 2009;15:613–24.CrossRefGoogle Scholar
  5. 5.
    Spiliopoulou A, Dimitriou G, Jelastopulu E, Giannakopoulos I, Anastassiou ED, Christofidou M. Neonatal Intensive Care Unit candidemia: epidemiology, risk factors, outcome, and critical review of published case series. Mycopathologia. 2012;173:219–28.PubMedCrossRefGoogle Scholar
  6. 6.
    Pedroso CPA, Krebs VLJ. Complications of systemic candidiasis in NICU. Revista de Ciências médicas biológicas. 2008;7(3):280–8.Google Scholar
  7. 7.
    Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics. 2006;117:84–92.PubMedCrossRefGoogle Scholar
  8. 8.
    Lavarde VF, Saez DH, Arnold M, Faguer B. Peritonite mycosique a Torulopsis haemulonii. Bull Soc Fr Mycol Med. 1984;13:173–6.Google Scholar
  9. 9.
    Khan ZU, Al-Sweih NA, Ahmad S, Al-Kazemi N, Khan S, Joseph L, Chandy R. Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole. J Clin Microbiol. 2007;45:2025–7.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Cendejas-Bueno E, Kolecka A, Alastruey-Izquierdo A, Theelen B, Groenewald M, Kostrzewa M, Cuenca-Estrella M, Gómez-López A, Boekhout T. Reclassification of the Candida haemulonii Complex as Candida haemulonii (C. haemulonii Group I), C. duobushaemulonii sp. nov. (C. haemulonii Group II), and C. haemulonii var. vulnera var. nov.: three multiresistant human pathogenic yeasts. J Clin Microbiol. 2012;50:3641–51.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Kim S, Ko KS, Moon SY, Lee MS, Son JS. Catheter-related Candidemia caused by Candida haemulonii in a patient in Long-term hospital care. J Korean Med Sci. 2011;26(2):297–300.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Barnett JA, Paine RW, Yarrow D. Yeasts: characteristics and identification. Cambridge: Cambridge University Press; 2000.Google Scholar
  13. 13.
    White TJBT, Lee S, Taylor J. Amplification and direct sequence of fungal ribosomal RNA genes for phylogenetics. In: Innis MAGD, Sninsky J, White TJ, editors. PCR protocols, a guide to methods and applications. New York: Academic Press; 1990. p. 315–22.Google Scholar
  14. 14.
    Lima-Neto RG, Santos C, Lima N, Sampaio P, Pais C, Neves RP. Application of MALDI-TOF MS for requalification of Candida clinical isolates culture collection. Braz J Microbiol. 2014;45(2):515–522.Google Scholar
  15. 15.
    Clinical and Laboratory Standards Institute (CLSI). Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, 3rd ed. CLSI document M27-A3, Wayne, PA, 2008.Google Scholar
  16. 16.
    Marjolet M. Torulopsis ernobii, Torulopsis haemulonii: levures opportunistes chez I’immunode ´prime´? Bull Soc Fr Mycol Med. 1986;15:143–6.Google Scholar
  17. 17.
    Rodero L, Cuenca-Estrella S, Cordoba P, et al. Transient fungemia caused by an amphotericin B-resistant isolate of Candida haemulonii. J Clin Microbiol. 2002;40:2266–9.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Giusiano G, Mangiaterra M, Garcia Saito V, Rojas F, Gomez V, Diaz MC. Fluconazole and itraconazole resistance of yeasts isolated from the bloodstream and catheters of hospitalized pediatric patients. Chemotherapy. 2006;52:254–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Ruan SY, Kuo YW, Huang CT, Hsiue HC, Hsueh PR. Infections due to Candida haemulonii: species identification, antifungal susceptibility and outcomes. Int J Antimicrob Agents. 2010;35:85–8.PubMedCrossRefGoogle Scholar
  20. 20.
    Almeida JN Jr, Motta AL, Rossi F, et al. First report of a clinical isolate of Candida haemulonii in Brazil. Clinics. 2012;67(10):1229–31.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Muro MD, Motta FA, Burguer M, Melo ASA, Dalla-Costa LM. Echinocandin resistance in two Candida haemulonii isolates from pediatrics patients. J Clin Microbiol. 2012;50(11):3783.PubMedCrossRefGoogle Scholar
  22. 22.
    CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts: fourth informational supplement. CLSI document M27-S4. Wayne, PA, 2012.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  • Carolina M. Silva
    • 1
  • Ana M. R. Carvalho-Parahym
    • 1
  • Danielle P. C. Macêdo
    • 1
  • Reginaldo G. Lima-Neto
    • 1
  • Elaine C. Francisco
    • 2
  • Analy S. A. Melo
    • 2
  • Maria da Conceição M. Silva
    • 3
  • Moacir B. Jucá
    • 3
  • Luciana R. B. Mello
    • 4
  • Rosemary M. J. Amorim
    • 1
  • Rejane P. Neves
    • 1
  1. 1.Federal University of PernambucoRecifeBrazil
  2. 2.Federal University of São PauloSão PauloBrazil
  3. 3.Memorial Guararapes HospitalJaboatão dos GuararapesBrazil
  4. 4.Real Portuguese HospitalRecifeBrazil

Personalised recommendations